|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care Medicine (Drs. Khassawneh, White, and Hiller), and Arkansas Cancer Research Center (Drs. Anaissie and Barlogie), University of Arkansas for Medical Sciences, Little Rock, AR.
Correspondence to: Peter White, Jr., MD, Pulmonary and Critical Care Division, Slot 555, 4301 West Markham St, Little Rock, AR 72205; e-mail: whitepeter{at}uams.edu
Study objective: To report the outcome of patients with autologous peripheral blood stem cell transplantation (PBSCT) receiving mechanical ventilation.
Design: Retrospective observational study.
Setting: Active hematopoietic stem cell transplantation center and a university hospital medical ICU.
Patients: Patients with autologous PBSCT receiving mechanical ventilation.
Method: A review of the medical records of patients with autologous PBSCT receiving mechanical ventilation. Data collection was restricted to the first episode of mechanical ventilation.
Results: A total of 78 autologous PBSCT patients received mechanical ventilation for > 24 h. Twenty patients (26%) were extubated and discharged alive from the hospital. Thirteen hospital survivors (60%) were alive at 6 months. Lung injury (LI), vasopressor use, and hepatic and renal failure (HRF) were used to predict survival after mechanical ventilation. Sixty patients (76%) had no organ failure, or had isolated LI or only required treatment with vasopressors. Their hospital survival and 6-month survival were 32% and 20%, respectively. Hospital and 6-month survival for the patients with HRF or LI and vasopressor use was 6% and 0%, respectively.
Conclusions: Prolonged mechanical ventilation and aggressive ICU support is justified for autologous PBSCT patients receiving mechanical ventilation with no organ failure, or who have only isolated LI, or who only require treatment with vasopressors.
Key Words: autologous transplantation bone marrow transplantation hematopoietic stem cell transplantation mechanical ventilators multiple myeloma multiple organ failure outcome assessment respiratory insufficiency survival
This article has been cited by other articles:
![]() |
G. Thiery, E. Azoulay, M. Darmon, M. Ciroldi, S. De Miranda, V. Levy, F. Fieux, D. Moreau, J. R. Le Gall, and B. Schlemmer Outcome of Cancer Patients Considered for Intensive Care Unit Admission: A Hospital-Wide Prospective Study J. Clin. Oncol., July 1, 2005; 23(19): 4406 - 4413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Soubani, E. Kseibi, J. J. Bander, J. L. Klein, G. Khanchandani, H. P. Ahmed, and J. A. Guzman Outcome and Prognostic Factors of Hematopoietic Stem Cell Transplantation Recipients Admitted to a Medical ICU Chest, November 1, 2004; 126(5): 1604 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Depuydt, D. D. Benoit, K. H. Vandewoude, J. M. Decruyenaere, and F. A. Colardyn Outcome in Noninvasively and Invasively Ventilated Hematologic Patients With Acute Respiratory Failure Chest, October 1, 2004; 126(4): 1299 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kotloff, V. N. Ahya, and S. W. Crawford Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Azoulay, F. Fieux, D. Moreau, G. Thiery, P. Rousselot, A. Parrot, J.-R. Le Gall, H. Dombret, and B. Schlemmer Acute Monocytic Leukemia Presenting as Acute Respiratory Failure Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1329 - 1333. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |